ANGONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends May 31
ANGIODYNAMICS INC
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 8, 2026
$11.39+0.15 (+1.33%)
Close on Oct 19, 2026
- Market cap
- $478.63M
- P/E (TTM)
- –
- Dividend yield
- –
ANGIODYNAMICS INC revenue by segment
By business segment
By product or service
| Revenue | TTM Q4 26 | TTM Q3 26 | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Med Device | – | – | – | – | – | $163.12M | $171.80M | $184.22M | $197.51M | $220.45M | $228.95M | $236.16M | – | – |
| Med Tech | – | – | – | – | – | $120.20M | $114.70M | $108.51M | $106.40M | $103.56M | $100.59M | $99.73M | – | – |
By region
| Revenue | TTM Q4 26 | TTM Q3 26 | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $274.92M | $268.81M | $262.87M | $257.96M | $250.98M | $244.24M | $245.24M | $246.57M | $251.49M | $265.18M | $270.46M | $278.09M | 85.9% | +9.5% |
| International | $45.25M | $44.91M | $44.43M | $42.76M | $41.52M | $39.08M | $41.25M | $46.16M | $52.43M | $58.83M | $59.08M | $57.81M | 14.1% | +9.0% |
From the segment and revenue-disaggregation notes of Angiodynamics's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.